2023 ACMG Annual Clinical Genetics Meeting Digital Edition: Poster Gallery-Workforce readiness for pharmacogenomics implementation and key elements for sustainment.

Pdf Summary

The document focuses on workforce readiness for the implementation of pharmacogenomics (PGx) in healthcare practice, specifically in the context of the Veterans Health Administration (VHA). The study finds that healthcare providers (HCPs) feel poorly informed about PGx and how to incorporate it into their practice, although providers from medical specialties with stronger evidence for PGx feel more knowledgeable. However, providers see value in PGx and desire more education on how to incorporate it into their practice.<br /><br />The document recommends the development of a national enterprise-wide program to ensure consistency, avoid redundancy, and minimize disparities. It also emphasizes the importance of a multi-disciplinary team approach in the PGx process, involving providers, pharmacies, and labs. The report highlights several key findings related to program development considerations, program structure and processes, provider experience, and program sustainment.<br /><br />The study includes both qualitative and quantitative findings. The qualitative findings are based on interviews with subject-matter experts across various specialty areas, and the quantitative findings are based on a survey sent to HCPs at a representative sample of VHAs. The survey measures knowledge and beliefs about PGx, current use and interest in PGx in practice, and preferences for PGx practice integration.<br /><br />Overall, the study concludes that even with strong evidence for clinical utility, there are workflow and workforce preparedness considerations that must be addressed before widespread implementation of PGx. It highlights the need for ongoing education and training, engagement of providers, and integration of PGx program data into existing clinical decision support mechanisms in order to enhance provider buy-in and sustain the program long-term.<br /><br />It is important to note that the document provides a summary of the findings and recommendations from the study, which focuses specifically on the VHA system. The findings may not be generalizable to all healthcare settings, and further research and implementation efforts are needed to fully understand and implement pharmacogenomics in healthcare practice.

Asset Subtitle

Presenting Author - R. Ryanne Wu, MD, MHS; Co-Author - Richelle Benevent, PhD; Co-Author - Nina Sperber, PhD; Co-Author - Jill S. Bates, PharmD, MS, BCOP, FASHP; Co-Author - Daniel Villa, BS; Co-Author - Dilhan Weeraratne, PhD; Co-Author - Timothy Burrell, MD, MBA; Co-Author - Deepak Voora, MD;

Meta Tag

Education

Genetic Testing

Pharmacogenomics

Risk Assessment

Co-Author Richelle Benevent, PhD

Co-Author Nina Sperber, PhD

Co-Author Jill S. Bates, PharmD, MS, BCOP, FASHP

Co-Author Daniel Villa, BS

Co-Author Dilhan Weeraratne, PhD

Co-Author Timothy Burrell, MD, MBA

Co-Author Deepak Voora, MD

Presenting Author R. Ryanne Wu, MD, MHS

Keywords

workforce readiness

pharmacogenomics

healthcare practice

Veterans Health Administration

healthcare providers

knowledge

education

program development

multi-disciplinary team

clinical utility